Adaptimmune Therapeutics (ADAP)
NASDAQ: ADAP
· Real-Time Price · USD
0.28
-0.00 (-1.06%)
At close: Jun 09, 2025, 3:58 PM
Adaptimmune Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 7.29M | 3.22M | 40.9M | 128.23M | 5.68M | 233.01K | 7.32M | 5.13M | 47.6M | 11.03M | 7.01M | 5.54M | 3.58M | 1.42M | 1.2M | 3.1M | 434K |
Cost of Revenue | 879K | n/a | n/a | 2.6M | 2.83M | 2.87M | 2.88M | 2.24M | 1.86M | 23.05M | 33.18M | 34.74M | 36.75M | 29.5M | 28.21M | 28.87M | 24.51M |
Gross Profit | 6.41M | 3.22M | 40.9M | 125.63M | 2.85M | -2.64M | 4.44M | 2.89M | 45.74M | -12.02M | -26.18M | -29.2M | -33.18M | -28.09M | -27.01M | -25.77M | -24.07M |
Operating Income | -45.73M | -73.52M | -14.68M | 68.7M | -49.26M | -54.02M | -46.29M | -44.91M | 1.66M | -27.24M | -42.99M | -43.75M | -49.98M | -42.86M | -42.18M | -39.31M | -37.89M |
Interest Income | 910K | 1.78M | 2.1M | 1.38M | 1.34M | 1.61M | 2.15M | 1.54M | 676K | 523K | 324K | 357K | 338K | 179K | 225K | 266K | 425K |
Pretax Income | -47.01M | -72.52M | -16.79M | 67.74M | -47.98M | -52.72M | -44.91M | -20.71M | 1.66M | -28.26M | -41.02M | -44.05M | -49.63M | -38.65M | -42.19M | -38.99M | -37.47M |
Net Income | -47.58M | -74.22M | -17.62M | 69.52M | -48.5M | -48.33M | -45.6M | -21.39M | 1.04M | -29.25M | -41.42M | -44.52M | -50.27M | -38.86M | -42.4M | -39.07M | -37.76M |
Selling & General & Admin | 23.28M | 21.22M | 21.28M | 16.36M | 19.73M | 14.15M | 16.16M | 20.07M | 20.4M | 15.22M | 16.82M | 16.89M | 16.8M | 14.78M | 15.17M | 14.99M | 13.82M |
Research & Development | 28.86M | 39.1M | 34.3M | 40.45M | 35.21M | 37.23M | 37.79M | 29.96M | 25.55M | 23.05M | 33.18M | 34.74M | 36.75M | 29.5M | 28.21M | 28.87M | 24.51M |
Other Expenses | n/a | 16.42M | n/a | n/a | -61K | -313K | -324K | 501K | -671K | -1.54M | 1.64M | -655K | 12K | 4.04M | -237K | 54K | -1K |
Operating Expenses | 52.14M | 76.74M | 55.58M | 59.53M | 54.94M | 51.38M | 53.95M | 50.04M | 45.95M | 38.27M | 50M | 49.29M | 53.56M | 44.28M | 43.38M | 42.41M | 38.32M |
Interest Expense | 1.88M | 1.71M | 1.11M | 526K | n/a | 5K | n/a | n/a | n/a | 1.01M | 324K | n/a | 338K | 179K | 225K | 266K | 425K |
Selling & Marketing Expenses | n/a | 506K | n/a | -2.72M | n/a | -2.73M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 53.02M | 74.42M | 55.58M | 59.53M | 54.94M | 54.25M | 53.95M | 50.04M | 45.95M | 38.27M | 50M | 49.29M | 53.56M | 44.28M | 43.38M | 42.41M | 38.32M |
Income Tax Expense | -575K | 1.69M | 831K | -1.86M | -526K | -4.39M | -687K | 680K | 625K | 994K | 399K | 470K | 634K | 210K | 208K | 76K | 298K |
Shares Outstanding (Basic) | 257.03M | 255.94M | 255.77M | 255.59M | 241.87M | 227.11M | 226.31M | 184.69M | 165.22M | 164.12M | 163.47M | 160.47M | 156.67M | 156.22M | 156.1M | 155.7M | 155.18M |
Shares Outstanding (Diluted) | 257.03M | 255.94M | 255.77M | 259.86M | 241.87M | 227.11M | 226.31M | 184.69M | 166.71M | 164.12M | 163.47M | 160.47M | 156.67M | 156.22M | 156.1M | 155.7M | 155.18M |
EPS (Basic) | -0.18 | -0.29 | -0.07 | 0.27 | -0.2 | -0.21 | -0.2 | -0.12 | 0.01 | -0.18 | -0.25 | -0.28 | -0.32 | -0.25 | -0.27 | -0.25 | -0.24 |
EPS (Diluted) | -0.18 | -0.29 | -0.07 | 0.27 | -0.2 | -0.21 | -0.2 | -0.12 | 0.01 | -0.18 | -0.25 | -0.28 | -0.32 | -0.25 | -0.27 | -0.25 | -0.24 |
EBITDA | -42.66M | -67.97M | -12.86M | 71.01M | -46.43M | -49.85M | -43.74M | -20.97M | -1.86M | -23.51M | -41.5M | -42.2M | -48.39M | -42.86M | -40.73M | -37.87M | -36.45M |
EBIT | -45.13M | -73.11M | -15.68M | 68.27M | -49.26M | -49.86M | -46.63M | -20.71M | -3.72M | -24.95M | -42.99M | -43.75M | -49.98M | -42.86M | -42.18M | -39.31M | -37.89M |
Depreciation & Amortization | 2.47M | 2.81M | 2.82M | 2.75M | 2.83M | 2.87M | 2.88M | 2.24M | 1.86M | 1.45M | 1.48M | 1.54M | 1.59M | 2.24M | 1.45M | 1.44M | 1.44M |